Select a region
North America Europe Asia
2013 RAPS Understanding the Regulatory Landscape for Adaptive Design Trials - June 2013 RAC: A Mark of Professional Distinction RAPS Fellows Advanced eCTD Submissions, 27–29 August 2013
2013 RAPS: Drive
Understanding the Regulatory Landscape for Adaptive Design Trials - June 2013
RAC: A Mark of Professional Distinction
RAPS Fellows
Advanced eCTD Submissions, 27–29 August 2013

RAPS & Regulatory

RAPS is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. Read more »

 Upcoming Events
Event: Chapter

Chapter Event
Expected Changes Under the New EU Device Regulations
29 May 2013 | Shoreview, MN

Event: Chapter

Chapter Event
Market Access Preliminary Skills (MAPS) for Regulatory Professionals
30 May 2013 | Lausanne, Switzerland

Event: RAPS Executive Development

Workshop
RAPS Executive Development
3–6 June 2013 | Evanston, IL

 Community
Join the discussion -- RAPS Regulatory Exchange

RE:Device clearance in the EU
Posted: 5/22/2013 10:16:02 AM
From : Discussion Post>>Regulatory Open Forum
If you are planning to sell products in Europe I will assume that you must be certified to ISO 13485 or will soon be seeking this certification. (This is technically not a requirement, but practically speaking is the simplest route.) The re...

RE:Device clearance in the EU
Posted: 5/22/2013 8:35:40 AM
From : Discussion Post>>Regulatory Open Forum
I think everyone has raised good points. I would only add some changes are underway for the EU system, which are important to know. If you have any questions don't hesitate to e-mail. ------------------------------------------- Marc Sanch...

RE:Device clearance in the EU
Posted: 5/22/2013 7:05:18 AM
From : Discussion Post>>Regulatory Open Forum
No. The most salient points in the US 510(k) clearance process is the concept of substantial equivalence. FDA defines the device risk class and provides additional requirements through the Product Code. A manufacturer demonstrates substantia...

Become a Member

Access 2012 RAPS Session Content


Regulatory Focus Online

Regulatory Focus Breaking global regulatory news and in-depth expert insight.

Read Regulatory Focus »

In the RAPS Store

RAPS The source for regulatory knowledgeThe source for regulatory knowledge.
RAC prep resources, Books, RAPS Online University courses, on-demand webcasts and more.

View more »